Article Details
Retrieved on: 2022-11-14 18:55:48
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Rituximab depletes B-cells, weakening immune response to infections. Trial findings were presented in a poster at this year's ACR Convergence, the ...
Article found on: ancavasculitisnews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here